Amendments to allow Gov’t to purchase “innovative” medicines at discounted prices
A new bill will allow the Georgian Government to purchase “innovative” medical drugs at discounted prices, in a bid to improve access to the products for customers, the Government Administration revealed on Monday. Photo: PM's press office
Tweet 
Share
A new bill will allow the Georgian Government to purchase “innovative” medical drugs at discounted prices, in a bid to improve access to the products for customers, the Government Administration revealed on Monday.
The initiative will introduce the internationally used Managed Entry Agreement system, which involves firms and healthcare payers and enables coverage of new drugs.
The coverage is designed to “manag[e] uncertainty around [the products’] financial impact or performance”, the Organisation for Economic Co-operation and Development says.
The Government Administration said the bill would “positively affect users of innovative original pharmaceutical products, increase access to innovative medicines and improve the efficiency of spending of public funds”.
The Georgian Government’s Interagency Commission has been authorised to set wholesale prices for select pharmaceutical products by Prime Minister Irakli Garibashvili, in the latest move designed to effect a reduction of domestic costs of medication.
The Regulation Agency for Medical and Pharmaceutical Activities of Georgia has “proactively” registered 563 medicines to simplify their import for domestic companies, the Ministry of Health announced on Friday.
Georgian Prime Minister Irakli Garibashvili, on Thursday, visited the first Drug Quality Control Laboratory in Georgia and said the Government had invested ₾11 million (about $4 mln) into the “ultra-modern” laboratory, which was essential for the Georgian people and the country.
Georgian Health Minister Zurab Azarashvili on Monday said the Ministry would finance "year-long medication needs" for oncology patients and was in talks with drug manufacturers.